Telos Capital Management, Inc. Abbott Laboratories Transaction History

Telos Capital Management, Inc.

$937 Million
Q3 2024

A detailed history of Telos Capital Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Telos Capital Management, Inc. holds 30,756 shares of ABT stock, worth $3.61 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

30,756

Previous 30,930 0.56%

Holding current value

$3.61 Million

Previous $3.21 Million 9.12%

% of portfolio

0.37%

Previous 0.36%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$100.07 - $118.13 $17,412 - $20,554	-174 Reduced 0.56%	30,756 $3.51 Million
Q2 2024 Jul 31, 2024	SELL	$100.73 - $112.44 $101,636 - $113,451	-1,009 Reduced 3.16%	30,930 $3.21 Million
Q1 2024 Apr 24, 2024	SELL	$109.52 - $120.96 $13,580 - $14,999	-124 Reduced 0.39%	31,939 $3.63 Million
Q4 2023 Jan 30, 2024	SELL	$90.19 - $110.4 $267,503 - $327,446	-2,966 Reduced 8.47%	32,063 $3.53 Million
Q2 2023 Jul 20, 2023	SELL	$100.78 - $112.29 $10,481 - $11,678	-104 Reduced 0.3%	35,029 $3.82 Million
Q1 2023 Apr 27, 2023	SELL	$96.86 - $114.01 $7,458 - $8,778	-77 Reduced 0.22%	35,133 $3.56 Million
Q4 2022 Jan 27, 2023	SELL	$95.06 - $111.52 $43,157 - $50,630	-454 Reduced 1.27%	35,210 $0
Q3 2022 Oct 31, 2022	BUY	$96.76 - $112.03 $100,436 - $116,287	1,038 Added 3.0%	35,664 $3.45 Million
Q2 2022 Aug 08, 2022	SELL	$102.07 - $123.37 $102,070 - $123,370	-1,000 Reduced 2.81%	34,626 $3.76 Million
Q1 2022 May 02, 2022	SELL	$114.02 - $139.04 $232,144 - $283,085	-2,036 Reduced 5.41%	35,626 $4.22 Million
Q4 2021 Jan 21, 2022	SELL	$115.53 - $141.46 $10,282 - $12,589	-89 Reduced 0.24%	37,662 $5.3 Million
Q3 2021 Oct 19, 2021	SELL	$116.66 - $129.06 $11,666 - $12,906	-100 Reduced 0.26%	37,751 $4.46 Million
Q2 2021 Jul 15, 2021	SELL	$105.79 - $124.53 $79,342 - $93,397	-750 Reduced 1.94%	37,851 $4.39 Million
Q1 2021 Apr 28, 2021	SELL	$108.84 - $128.23 $13,605 - $16,028	-125 Reduced 0.32%	38,601 $4.63 Million
Q4 2020 Feb 02, 2021	SELL	$105.0 - $114.42 $29,295 - $31,923	-279 Reduced 0.72%	38,726 $4.24 Million
Q3 2020 Oct 27, 2020	SELL	$91.64 - $111.29 $9,713 - $11,796	-106 Reduced 0.27%	39,005 $4.25 Million
Q2 2020 Jul 23, 2020	BUY	$76.57 - $98.0 $20,214 - $25,872	264 Added 0.68%	39,111 $3.58 Million
Q1 2020 May 01, 2020	BUY	$62.82 - $91.86 $1.53 Million - $2.24 Million	24,350 Added 167.97%	38,847 $3.07 Million
Q4 2019 Jan 23, 2020	BUY	$78.51 - $87.4 $564,015 - $627,881	7,184 Added 98.24%	14,497 $1.26 Million
Q3 2019 Oct 31, 2019	BUY	$81.84 - $88.74 $598,495 - $648,955	7,313 New	7,313 $612,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Telos Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Telos Capital Management, Inc. with notifications on news.

Account

Telos Capital Management, Inc. Abbott Laboratories Transaction History